論文・技術情報追加のお知らせ

①Identifying Safety Subgroups at Risk: Assessing the Agreement Between Statistical Alerting and Patient Subgroup Risk.

有害事象リスクのあるサブグループの特定、評価研究

対象DB：FAERS

②Evaluation of uveitis events in real-world patients receiving immune checkpoint inhibitors based on the FAERS database.

免疫チェックポイント阻害剤によるぶどう膜炎事象の評価研究

対象DB：FAERS

③Comparison of pneumonitis risk between immunotherapy alone and in combination with chemotherapy: an observational, retrospective pharmacovigilance study.

ICIと化学療法の併用と、他の薬剤レジメン間のCIPリスク比較研究

対象DB：FAERS、VigiBase

④The Effect of Concomitant Usage of Analgesics on Immune Checkpoint Inhibitor-related Interstitial Lung Disease.

ICI関連ILDの発症に対する鎮痛剤併用の影響についての評価研究

対象DB：JADER

⑤Evaluation of the Time to Onset and Outcome of Lenalidomide-induced Thrombosis and Embolism Using Spontaneous Reporting Database.

LNDによる血栓塞栓症の発生時期および転帰についての評価研究

対象DB：JADER

⑥Analysis of Adverse Events of Cholinesterase Inhibitors and NMDA Receptor Antagonists on Arrhythmias Using the Japanese Adverse Drug Event Report Database.

抗認知症薬と不整脈の関連性評価研究

対象DB：JADER

⑦Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials.

小児におけるCOVID-19ワクチンの安全性評価研究

対象DB：EudraVigilance

⑧Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database.

パルミチン酸パリペリドンの安全性と忍容性についての評価研究

対象DB：EudraVigilance